Cvs Berry Antacid Hbg Chews

Description

CVS Mixed Berry Antacid is formulated as a chewable tablet, available in a package containing 54 count. The product is designed to provide relief from heartburn and indigestion. Its mixed berry flavor enhances palatability, making it suitable for a variety of users seeking antacid relief.

Uses and Indications

This drug is indicated for the relief of heartburn, sour stomach, and acid indigestion. It is also effective in alleviating upset stomach associated with these symptoms. Additionally, this drug provides relief from bloating, pressure, or a stuffed feeling commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are advised to chew and swallow 1 to 2 chewable tablets every 2 to 4 hours as needed for symptom relief. It is important not to exceed a total of 5 chewable tablets within a 24-hour period.

For children under 12 years of age, consultation with a healthcare professional is recommended prior to administration.

Contraindications

The product should not be used at the maximum dosage for more than 2 weeks unless advised and supervised by a physician. This limitation is in place to mitigate potential risks associated with prolonged high-dose use. No other contraindications have been specified in the provided data.

Warnings and Precautions

Patients with a history of allergic reactions to this product or any of its ingredients should not use it. This contraindication is critical to prevent severe allergic responses.

It is advised that the maximum dosage not be utilized for a duration exceeding two weeks unless specifically directed and monitored by a physician. Adhering to this guideline is essential to mitigate the risk of potential adverse effects associated with prolonged high-dose usage.

Currently, there are no specific laboratory tests recommended for monitoring during the use of this product. Healthcare professionals should remain vigilant and assess the patient's overall health and response to treatment as necessary.

In the event of any concerning symptoms or adverse reactions, patients should seek immediate medical assistance. Additionally, if any unexpected side effects occur, it is imperative for patients to discontinue use and consult their healthcare provider for further evaluation and guidance.

Side Effects

Patients should be aware that the use of this product is contraindicated in individuals who have a history of allergic reactions to the product or any of its ingredients. This warning is critical to prevent serious allergic responses that may occur upon administration.

In clinical trials and postmarketing experiences, no additional adverse reactions have been reported beyond those associated with allergic reactions. Therefore, careful screening for prior allergic history is essential before initiating treatment with this product to ensure patient safety.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Patients should be counseled to separate the dosing of antacids and other prescribed drugs by at least two hours when possible to ensure optimal therapeutic outcomes.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Berry Antacid Hbg Chews (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may chew and swallow 1 to 2 chewable tablets every 2 to 4 hours as needed, without exceeding 5 chewable tablets in a 24-hour period. For children under 12 years of age, it is advised to consult a doctor prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of antidotes or specific treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has revealed additional information regarding the safety profile of the product. Adverse events have been reported voluntarily by healthcare professionals and patients, as well as through surveillance programs.

For inquiries or to report an adverse event, individuals are encouraged to contact the designated support line at 1-800-245-2898, available Monday through Friday from 9 AM to 4 PM EST.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion.

Patients should be informed not to exceed the maximum dosage for more than two weeks unless directed by a physician. It is important for patients to understand the potential for constipation as a side effect when using this product.

Additionally, healthcare providers should encourage patients to consult with a doctor or pharmacist before using this product if they are currently taking any prescription medications. This is particularly crucial as antacids may interact with certain prescription drugs, and such interactions could affect the efficacy of their treatment.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a dry place, maintaining a temperature range of 20° to 25°C (68° to 77°F) to ensure optimal stability and efficacy. Proper handling and storage conditions are crucial for preserving the integrity of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Cvs Berry Antacid Hbg Chews, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)